Sandu Pharmaceuticals Limited has appointed M/s. Dave & Dave, Chartered Accountants, as its new statutory auditors. This appointment is for a term of five consecutive financial years, commencing from the Financial Year 2026-27 until the conclusion of the Annual General Meeting in 2031. The change follows the completion of the term for the previous auditors, M/s Dileep and Prithvi.
New Statutory Auditors Appointed
Sandu Pharmaceuticals Limited has announced the appointment of M/s. Dave & Dave, Chartered Accountants, as its new statutory auditors. This significant decision was made during a meeting of the company’s members, effective from the conclusion of the 41st Annual General Meeting held on September 11, 2026.
Extended Tenure
The firm, M/s. Dave & Dave, will serve as the statutory auditors for a period of five consecutive financial years. Their term is set to commence with the Financial Year 2026-27 and will continue until the conclusion of the Annual General Meeting scheduled for the year 2031. This appointment replaces the outgoing auditors, M/s Dileep and Prithvi, whose tenure expired on September 11, 2026, upon the conclusion of the 41st Annual General Meeting.
Auditor Background
M/s. Dave & Dave, Chartered Accountants, is a partnership firm established in 1989, with Firm Registration No. 102163W. The firm holds a valid Peer Review Certificate No. 020259, which is valid until March 2028. They possess extensive experience in statutory, internal, and tax audits, as well as corporate law and secretarial compliances. The firm has confirmed it has no relation with the directors or key managerial personnel of Sandu Pharmaceuticals.
Source: BSE
